MEMBRANOUS NEPHROPATHY

Clinical trials for MEMBRANOUS NEPHROPATHY explained in plain language.

Never miss a new study

Get alerted when new MEMBRANOUS NEPHROPATHY trials appear

Sign up with your email to follow new studies for MEMBRANOUS NEPHROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 8 Not yet recruiting 1 Not yet finished but already full! 1 Completed 3 Terminated 1

New drug tested for rare kidney disease halted early

Disease control Terminated

This early-stage study tested a new drug called VB119 for adults with primary membranous nephropathy, a kidney disease that causes harmful protein loss in urine. The main goal was to find a safe dose and see how the body processes the drug. The study was terminated early and only…

Matched conditions: MEMBRANOUS NEPHROPATHY

Phase: PHASE1, PHASE2 • Sponsor: Tenet Medicines • Aim: Disease control

Last updated Mar 18, 2026 14:40 UTC

MEMBRANOUS NEPHROPATHY

Get alerted when new MEMBRANOUS NEPHROPATHY trials appear

New drug tested for rare kidney disease halted early